Content
03/17/2025
Plymouth, MN USA
Laplace Interventional
completed $22 million Series C Round funding. Investors include
Unorthodox Ventures, Engage Venture Partners, JWC Venture, Features Capital.
About
Laplace Interventional is developing a minimally invasive transcatheter treatment for patients suffering from Tricuspid Regurgitation.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
